Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms
Abstract Clonal hematopoiesis of indeterminate potential is the primary pathogenic risk factor for myeloid neoplasms, while heteroplasmy (mutations in a subset of cellular mitochondrial DNA) is another marker of clonal expansion associated with hematological malignancies. We explore how these two ma...
Saved in:
| Main Authors: | Yun Soo Hong, Sergiu Pasca, Wen Shi, Daniela Puiu, Nicole J. Lake, Monkol Lek, Meng Ru, Megan L. Grove, Anna Prizment, Corinne E. Joshu, Elizabeth A. Platz, Eliseo Guallar, Dan E. Arking, Lukasz P. Gondek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54443-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Age-Related and Heteroplasmy-Related Variation in Human mtDNA Copy Number.
by: Manja Wachsmuth, et al.
Published: (2016-03-01) -
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
by: John P Grady, et al.
Published: (2018-05-01) -
Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
by: M. V. Makarova, et al.
Published: (2024-04-01) -
Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions
by: Tamara Westover, et al.
Published: (2025-05-01) -
Strategies for identifying <i>NUP98</i> rearrangements in adult myeloid neoplasms
by: Lisa D. Yuen, et al.
Published: (2025-08-01)